<p>Expressing "serious concern" over the impact of the prevailing FDI policy for brownfield investments in the pharmaceutical sector, Commerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.<br /><br /></p>.<p>"Foreign Direct Investment (FDI) in the pharma sector has neither proved to be an additionality in terms of creation of production facilities nor has it strengthened the R&D in the country.”<br /><br />“These facts make a compelling case for revisiting the FDI policy on brownfield pharma," Sharma said in a letter addressed to Prime Minister Manmohan Singh.<br /><br />"I would urge the PM to call an urgent high-level review meeting, along with Finance Minister, Health Minister, Pharmaceutical Minister, and the undersigned (myself) to deliberate on the matter," he said.<br /></p>
<p>Expressing "serious concern" over the impact of the prevailing FDI policy for brownfield investments in the pharmaceutical sector, Commerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.<br /><br /></p>.<p>"Foreign Direct Investment (FDI) in the pharma sector has neither proved to be an additionality in terms of creation of production facilities nor has it strengthened the R&D in the country.”<br /><br />“These facts make a compelling case for revisiting the FDI policy on brownfield pharma," Sharma said in a letter addressed to Prime Minister Manmohan Singh.<br /><br />"I would urge the PM to call an urgent high-level review meeting, along with Finance Minister, Health Minister, Pharmaceutical Minister, and the undersigned (myself) to deliberate on the matter," he said.<br /></p>